You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR FLECAINIDE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for flecainide acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002996 ↗ Flecainide in Treating Patients With Chronic Neuropathic Pain Completed National Cancer Institute (NCI) Phase 2 1998-02-01 RATIONALE: Flecainide therapy may help patients with neuropathic pain live more comfortably. PURPOSE: Phase II trial to study the effectiveness of flecainide in treating patients with chronic neuropathic pain from cancer or AIDS.
NCT00002996 ↗ Flecainide in Treating Patients With Chronic Neuropathic Pain Completed Eastern Cooperative Oncology Group Phase 2 1998-02-01 RATIONALE: Flecainide therapy may help patients with neuropathic pain live more comfortably. PURPOSE: Phase II trial to study the effectiveness of flecainide in treating patients with chronic neuropathic pain from cancer or AIDS.
NCT00189319 ↗ To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation Completed MEDA Pharma GmbH & Co. KG Phase 4 2003-09-01 The purpose of this study is to evaluate the management of paroxysmal atrial fibrillation with controlled release flecainide on patient's quality of life.
NCT01117454 ↗ Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia Completed Vanderbilt University N/A 2011-12-01 The purpose of this study is to test whether the addition of oral flecainide to standard therapy will reduce ventricular ectopy on exercise test compared to placebo plus standard therapy in patients with Catecholaminergic Polymorphic Ventricular Tachycardia.
NCT01117454 ↗ Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia Completed Vanderbilt University Medical Center N/A 2011-12-01 The purpose of this study is to test whether the addition of oral flecainide to standard therapy will reduce ventricular ectopy on exercise test compared to placebo plus standard therapy in patients with Catecholaminergic Polymorphic Ventricular Tachycardia.
NCT03539302 ↗ INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) Recruiting InCarda Therapeutics Australia Pty Ltd. Phase 2 2018-05-29 The study consists of 3 parts (Part A, Part B and Part C). Part A was an open-label, randomized, multi center design to evaluate the feasibility of administration of inhaled flecainide in two dosing regimens. Part B was an open-label, multicenter design to confirm the safety (including tolerability) and efficacy of the optimal inhaled flecainide dose determined from Part A. Part C is currently ongoing and is an open-label, multi center study with exploratory objectives to explore the feasibility of patient-led self administration of flecainide. Part C also includes an exploratory sub-study to assess the feasibility of implementing a portable cardiac ultrasound (HHE) at screening in an emergent setting.
NCT03539302 ↗ INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) Recruiting InCarda Therapeutics, Inc. Phase 2 2018-05-29 The study consists of 3 parts (Part A, Part B and Part C). Part A was an open-label, randomized, multi center design to evaluate the feasibility of administration of inhaled flecainide in two dosing regimens. Part B was an open-label, multicenter design to confirm the safety (including tolerability) and efficacy of the optimal inhaled flecainide dose determined from Part A. Part C is currently ongoing and is an open-label, multi center study with exploratory objectives to explore the feasibility of patient-led self administration of flecainide. Part C also includes an exploratory sub-study to assess the feasibility of implementing a portable cardiac ultrasound (HHE) at screening in an emergent setting.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for flecainide acetate

Condition Name

Condition Name for flecainide acetate
Intervention Trials
Paroxysmal Atrial Fibrillation 1
Paroxysmal Atrial Fibrillation (PAF) 1
Atrial Fibrillation 1
Catecholaminergic Polymorphic Ventricular Tachycardia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for flecainide acetate
Intervention Trials
Atrial Fibrillation 3
Neuralgia 1
Tachycardia, Ventricular 1
Tachycardia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for flecainide acetate

Trials by Country

Trials by Country for flecainide acetate
Location Trials
United States 12
Netherlands 1
Belgium 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for flecainide acetate
Location Trials
Tennessee 1
Ohio 1
North Carolina 1
New York 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for flecainide acetate

Clinical Trial Phase

Clinical Trial Phase for flecainide acetate
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for flecainide acetate
Clinical Trial Phase Trials
Completed 3
Recruiting 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for flecainide acetate

Sponsor Name

Sponsor Name for flecainide acetate
Sponsor Trials
InCarda Therapeutics, Inc. 2
National Cancer Institute (NCI) 1
Eastern Cooperative Oncology Group 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for flecainide acetate
Sponsor Trials
Industry 4
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.